Thomas Lahlali

403 total citations
12 papers, 242 citations indexed

About

Thomas Lahlali is a scholar working on Hepatology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas Lahlali has authored 12 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Epidemiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas Lahlali's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Axon Guidance and Neuronal Signaling (4 papers). Thomas Lahlali is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Axon Guidance and Neuronal Signaling (4 papers). Thomas Lahlali collaborates with scholars based in France, Spain and United States. Thomas Lahlali's co-authors include Fabien Zoulim, David Durantel, Koen Vandyck, Frederik Pauwels, Karen Vergauwen, Jan Martin Berke, François–Loïc Cosset, Manuel Rosa‐Calatrava, Ourania Andrisani and Nathalie Isorce and has published in prestigious journals such as Hepatology, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas Lahlali

12 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Lahlali France	9	138	116	77	52	22	12	242
Lester Suárez-Amarán Spain	6	85 0.6×	54 0.5×	158 2.1×	52 1.0×	6 0.3×	6	315
Xuemei Feng China	9	57 0.4×	41 0.4×	104 1.4×	64 1.2×	10 0.5×	31	264
Hualong Xiong China	7	64 0.5×	42 0.4×	69 0.9×	41 0.8×	8 0.4×	11	169
Amit Nathwani United Kingdom	3	117 0.8×	77 0.7×	36 0.5×	24 0.5×	3 0.1×	4	189
A. Spaziani Italy	10	89 0.6×	93 0.8×	101 1.3×	76 1.5×	4 0.2×	15	335
Chun Shen Lim New Zealand	10	41 0.3×	28 0.2×	164 2.1×	16 0.3×	15 0.7×	20	283
Piyush Dravid United States	9	44 0.3×	39 0.3×	73 0.9×	43 0.8×	4 0.2×	15	220
Carolyn Spaniel United States	4	82 0.6×	126 1.1×	269 3.5×	28 0.5×	2 0.1×	4	379
Marti Cabanes‐Creus Australia	10	51 0.4×	42 0.4×	216 2.8×	36 0.7×	6 0.3×	13	335
Xiping Zhao China	11	263 1.9×	260 2.2×	55 0.7×	24 0.5×	3 0.1×	20	385

Countries citing papers authored by Thomas Lahlali

Since Specialization

Citations

This map shows the geographic impact of Thomas Lahlali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lahlali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lahlali more than expected).

Fields of papers citing papers by Thomas Lahlali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lahlali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lahlali. The network helps show where Thomas Lahlali may publish in the future.

Co-authorship network of co-authors of Thomas Lahlali

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lahlali. A scholar is included among the top collaborators of Thomas Lahlali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lahlali. Thomas Lahlali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lahlali, Thomas, Grégory Neveu, Christine C. Siska, et al.. (2024). AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains. PubMed. 7(4). 307–323. 4 indexed citations

Salasc, Fanny, Thomas Lahlali, Emilie Laurent, Manuel Rosa‐Calatrava, & Andrés Pizzorno. (2021). Treatments for COVID-19: Lessons from 2020 and new therapeutic options. Current Opinion in Pharmacology. 62. 43–59. 23 indexed citations

Lahlali, Thomas, Julie Lucifora, Anna Salvetti, et al.. (2019). Antiviral Activity of PLK1-Targeting siRNA Delivered by Lipid Nanoparticles in HBV-Infected Hepatocytes. Antiviral Therapy. 25(3). 151–162. 11 indexed citations

Christensen, Stefan, Patrick Ingiliz, Knud Schewe, et al.. (2018). Significant changes of HCV patient characteristics over time in the era of direct antiviral agent therapy – are all HCV subpopulations treated similarly? – Results from the German hepatitis C Cohort. Journal of Hepatology. 68. S289–S290. 3 indexed citations

Lahlali, Thomas, Jan Martin Berke, Karen Vergauwen, et al.. (2018). Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle. Antimicrobial Agents and Chemotherapy. 62(10). 76 indexed citations

Lahlali, Thomas, Marie‐Laure Plissonnier, Cristina Romero‐López, et al.. (2017). Hepatocellular carcinoma-associated depletion of the netrin-1 receptor Uncoordinated Phenotype-5A (UNC5A) skews the hepatic unfolded protein response towards prosurvival outcomes. Biochemical and Biophysical Research Communications. 495(4). 2425–2431. 4 indexed citations

Plissonnier, Marie‐Laure, Thomas Lahlali, Marc S. Raab, et al.. (2017). Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus. Oncogene. 36(48). 6712–6724. 9 indexed citations

Romero‐López, Cristina, et al.. (2017). Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome. Molecules. 22(5). 861–861. 8 indexed citations

Diab, Ahmed, Floriane Fusil, Thomas Lahlali, et al.. (2017). Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication. Hepatology. 66(6). 1750–1765. 58 indexed citations

10.

Lahlali, Thomas, Marie‐Laure Plissonnier, Cristina Romero‐López, et al.. (2016). Netrin-1 Protects Hepatocytes Against Cell Death Through Sustained Translation During the Unfolded Protein Response. Cellular and Molecular Gastroenterology and Hepatology. 2(3). 281–301.e9. 11 indexed citations

11.

Plissonnier, Marie‐Laure, Thomas Lahlali, Maud Michelet, et al.. (2016). Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus. PLoS Biology. 14(3). e1002421–e1002421. 14 indexed citations

12.

Parent, Romain, David Durantel, Thomas Lahlali, et al.. (2014). An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium. Biochemical and Biophysical Research Communications. 450(1). 7–12. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact